Raynews

Rayner acquires Omidria to expand surgical offering in USA and Europe

Posted on 2/12/2021

DECEMBER 02, 2021 – Worthing, United Kingdom. Rayner Surgical Group (‘Rayner’) and Omeros Corporation (‘Omeros’) are delighted to announce the transfer of Omeros’ ophthalmology assets, including OmidriaTM, to Rayner. This will enable the creation of a significant commercial, regulatory and marketing infrastructure in the US, with a broad range of products, including intraocular lenses (IOLs), for cataract surgeons.

Read more


Rayner appoints VP Corporate Development to lead global commercial expansion

Posted on 24/11/2021

NOVEMBER 24, 2021 – Worthing, United Kingdom. Rayner, a leading ophthalmology company focused on optimising visual outcomes for patients and surgeons, today announced the appointment of Dr Rob Nadler to the role of VP Corporate Development. Dr Nadler will play a critical role on the executive team, overseeing the company’s M&A strategy and brings invaluable clinical,

Read more


Rayner announces 1,000 IOLs recorded on RayPRO digital platform

Posted on 4/08/2021

AUGUST 04, 2021 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract and refractive surgery, announced today that it has achieved the milestone figure of 1,000 intraocular lenses recorded on RayPRO, its digital patient reported outcomes platform. Launched at ASCRS in 2019 for ophthalmic surgeons who perform cataract procedures, RayPRO is

Read more


Rayner Acquires Surgicon Healthcare Pvt Limited

Posted on 18/06/2021

JUNE 18, 2021 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract and refractive surgery, announced today that it has acquired Surgicon Healthcare Pvt Limited in Mumbai, India. The acquisition closed on Friday 18th June 2021. Acquisition Details Rayner has acquired its exclusive Indian distributor, Surgicon, for an undisclosed price. The

Read more


Rayner Receives Third FDA Approval in RayOne IOL Portfolio

Posted on 17/05/2021

New York, USA, May 17, 2021 – RayOne Spheric, a fully-preloaded monofocal IOL, has received FDA approval. This achievement marks Rayner’s third FDA approval in under three years within its expanding RayOne preloaded IOL portfolio. RayOne Spheric joins RayOne Aspheric (FDA approved December 2018) and RayOne EMV, a new non-diffractive IOL solution which achieved FDA

Read more


Rayner’s RayOne Aspheric preloaded IOL launches in China

Posted on 10/05/2021

Takeaways: Rayner’s fully preloaded RayOne Aspheric IOL has received NMPA approval for sale in China. RayOne Aspheric will be showcased at the 21st CSCRS from 3-5 June 2021 in Dalian. RayOne Aspheric offers a premium alternative to Rayner’s C-flex/Superflex Aspheric monofocal IOLs. Rayner’s award-winning RayOne IOL platform has been used in over 1.6 million procedures since 2016. Rayner will next

Read more


Rayner Launches the Plus1 EMV Campaign on Monovision Education, Announces Partnership with Medevise Consulting

Posted on 6/05/2021

Worthing, UK, 3 May 2021 – With the global rollout of the RayOne EMV™ intraocular lens to markets around the world, Rayner announces today an exciting new campaign intended to extoll the benefits of monovision (including “Mini”, “Micro”, or “Blended”). The Plus1 EMV: A global discussion on Enhanced Monovision™ campaign will shine a light on

Read more


Rayner awarded exclusive AEO customs status

Posted on 1/04/2021

Worthing, UK – Rayner, the only British manufacturer of intraocular lenses (IOLs), has been successfully awarded Authorised Economic Operator (AEO) status by HM Revenue & Customs. AEO status is an internationally recognised quality mark indicating that Rayner’s role in the international supply chain is secure and that its customs controls and procedures are efficient and

Read more


RayOne EMV IOL (Rayner) Receives FDA Approval

Posted on 26/03/2021

New York, USA, March 26, 2021 – RayOne EMV, a new fully preloaded non-diffractive IOL, has received FDA approval. RayOne EMV was developed in collaboration with world renowned surgeon Professor Graham Barrett, president of the Australasian Society of Cataract & Refractive Surgeons. “I collaborated with Rayner on bringing to market RayOne EMV, an exciting new product

Read more


Rayner Continues Growth in North America with Direct Presence in Canada

Posted on 21/01/2021

Worthing, UK – Following the recent approval of incorporation, Rayner is proud to announce its direct entry into the Canadian ophthalmology market. Led by Wade Allen, Director: Americas, Rayner Surgical Corp will now be offering the Rayner portfolio of IOLs and injectors directly to Canadian surgeons. Rayner Surgical Corp has recently had the RayOne Aspheric

Read more